Literature DB >> 3754138

In vitro inhibition by gossypol of oxidoreductases from human tissues.

C Burgos, N M Gerez de Burgos, L E Rovai, A Blanco.   

Abstract

The effect of gossypol, a polyphenolic compound with antifertility action on human males, has been investigated on the following oxidoreductases purified from human tissues: lactate dehydrogenase (EC 1.1.1.27) isozymes 1 or B4 from heart, 5 or A4 from liver and X or C4 from spermatozoa; malate dehydrogenase (EC 1.1.1.37) mitochondrial and "soluble" isozymes from heart and NADP-glutamate dehydrogenase (EC 1.4.1.4) from liver. Gossypol proved to be a powerful inhibitor of the six enzymes studied. For all of them, inhibition was of the competitive type with respect to the coenzyme and non-competitive in relation to substrate. The lowest ki values were shown for lactate dehydrogenase isozyme 1 or B4 and for the two isozymes of malate dehydrogenase. Results did not show selectivity of gossypol for the sperm-specific isozyme X or C4 of lactate dehydrogenase.

Entities:  

Keywords:  Clinical Research; Contraception; Contraceptive Agents; Contraceptive Agents, Male; Examinations And Diagnoses; Family Planning; Gossypol; In Vitro; Laboratory Examinations And Diagnoses; Laboratory Procedures; Research Methodology

Mesh:

Substances:

Year:  1986        PMID: 3754138     DOI: 10.1016/0006-2952(86)90248-0

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  5 in total

Review 1.  Aldehyde dehydrogenase inhibitors: a comprehensive review of the pharmacology, mechanism of action, substrate specificity, and clinical application.

Authors:  Vindhya Koppaka; David C Thompson; Ying Chen; Manuel Ellermann; Kyriacos C Nicolaou; Risto O Juvonen; Dennis Petersen; Richard A Deitrich; Thomas D Hurley; Vasilis Vasiliou
Journal:  Pharmacol Rev       Date:  2012-04-27       Impact factor: 25.468

2.  Aldehyde dehydrogenase is used by cancer cells for energy metabolism.

Authors:  Joon Hee Kang; Seon-Hyeong Lee; Dongwan Hong; Jae-Seon Lee; Hee-Sung Ahn; Ju-Hyun Ahn; Tae Wha Seong; Chang-Hun Lee; Hyonchol Jang; Kyeong Man Hong; Cheolju Lee; Jae-Ho Lee; Soo-Youl Kim
Journal:  Exp Mol Med       Date:  2016-11-25       Impact factor: 8.718

3.  Aldehyde dehydrogenase inhibition combined with phenformin treatment reversed NSCLC through ATP depletion.

Authors:  Joon Hee Kang; Seon-Hyeong Lee; Jae-Seon Lee; Boas Nam; Tae Wha Seong; Jaekyoung Son; Hyonchol Jang; Kyeong Man Hong; Cheolju Lee; Soo-Youl Kim
Journal:  Oncotarget       Date:  2016-08-02

4.  Targeting Oxidative Phosphorylation Reverses Drug Resistance in Cancer Cells by Blocking Autophagy Recycling.

Authors:  Jae-Seon Lee; Ho Lee; Hyonchol Jang; Sang Myung Woo; Jong Bae Park; Seon-Hyeong Lee; Joon Hee Kang; Hee Yeon Kim; Jaewhan Song; Soo-Youl Kim
Journal:  Cells       Date:  2020-09-01       Impact factor: 6.600

5.  Development of a Retinal-Based Probe for the Profiling of Retinaldehyde Dehydrogenases in Cancer Cells.

Authors:  Sebastiaan T A Koenders; Lukas S Wijaya; Martje N Erkelens; Alexander T Bakker; Vera E van der Noord; Eva J van Rooden; Lindsey Burggraaff; Pasquale C Putter; Else Botter; Kim Wals; Hans van den Elst; Hans den Dulk; Bogdan I Florea; Bob van de Water; Gerard J P van Westen; Reina E Mebius; Herman S Overkleeft; Sylvia E Le Dévédec; Mario van der Stelt
Journal:  ACS Cent Sci       Date:  2019-12-12       Impact factor: 14.553

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.